Stéphanie Hilbold, director of quality assurance and regulatory affairs at RDS, said: “Achieving this pivotal milestone is testament to the hard work of our technical development teams in recent years – working in close collaboration with the RDS department for quality assurance and regulatory affairs – alongside the many other teams and partners involved in developing this device. It demonstrates our company’s ongoing commitment to innovation and excellence in the field of medical technology.”

MultiSense is a Remote Patient Monitoring device comprised of a wearable electronic patch, a secure online platform and associated support services. The current version allows healthcare professionals to remotely monitor six physiological parameters – heart rate, respiratory rate, oxygen saturation, skin temperature, patients’ level of activity and body posture – in real-time – to the same standard as a clinical monitoring system. The device has been tested in six clinical trials.